Drug incorporating and release polymeric coating for bioprosthesis
First Claim
1. A method of making an article for localized delivery of a biologically active compound to a subject, said method comprising:
- (a) treating a medical-grade, polyurethane polymer coating on a substrate with a coating expansion solution at a temperature, under a pressure and for a time sufficient to cause the biologically active compound to substantially penetrate throughout the entire thickness of the polymer coating,said polymer coating having a thickness of at least 20 microns,said coating expansion solution comprising the biologically active compound and an organic solvent system,wherein the organic solvent system comprises at least one solvent for the polymer coating and at least one non-solvent for the polymer coating, wherein the solvent and the non-solvent are present in the organic solvent system at a ratio of solvent to non-solvent in the range of about 1;
1 to about 1;
20 by volume,wherein the biologically active compound is present in the coating expansion solution in a concentration of at least 0.1 parts per 100 parts of the organic solvent system; and
then(b) drying the thus treated polymer coating to substantially eliminate the organic solvent system.
0 Assignments
0 Petitions
Accused Products
Abstract
In accordance with the present invention, there are provided prosthetic articles having polyurethane coatings with biologically active compounds incorporated within the interstices of the polymer. Methods for the preparation of such articles are also provided. Thus, a polyurethane coating is applied to a prosthetic article, the coating then swelled (without significantly dissolving the polymer) so that substantial quantities of biologically active compounds can be incorporated within the interstices of the polymer. Upon long term exposure of a prosthetic article of the invention to physiological conditions, the biologically active compound is slowly released by the treated polymer. The biologically active compound is, therefore, released only at the site where it is desired, i.e., where the prosthetic article is positioned.
-
Citations
27 Claims
-
1. A method of making an article for localized delivery of a biologically active compound to a subject, said method comprising:
-
(a) treating a medical-grade, polyurethane polymer coating on a substrate with a coating expansion solution at a temperature, under a pressure and for a time sufficient to cause the biologically active compound to substantially penetrate throughout the entire thickness of the polymer coating, said polymer coating having a thickness of at least 20 microns, said coating expansion solution comprising the biologically active compound and an organic solvent system, wherein the organic solvent system comprises at least one solvent for the polymer coating and at least one non-solvent for the polymer coating, wherein the solvent and the non-solvent are present in the organic solvent system at a ratio of solvent to non-solvent in the range of about 1;
1 to about 1;
20 by volume,wherein the biologically active compound is present in the coating expansion solution in a concentration of at least 0.1 parts per 100 parts of the organic solvent system; and
then(b) drying the thus treated polymer coating to substantially eliminate the organic solvent system. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
-
-
26. A method of making an article for localized delivery of a biologically active compound to a subject, said method comprising:
-
(a) contacting an article comprising a metallic stent having a medical grade polyurethane polymer coating thereon, with a coating expansion solution at room temperature for about 1 minute to about 30 minutes, wherein the polymer coating has a thickness of at least about 20 microns, and wherein the medical grade polyurethane polymer is the reaction product of a high molecular weight polyether polyol having the structure;
space="preserve" listing-type="equation">H--(O--CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.2).sub.n --OHwherein n is such that the molecular weight of said polyether polyol is about 500 to about 5000, with about 1 to about 5 parts per part polyether polyol of an aliphatic diisocyanate, wherein the aliphatic diisocyanate is selected from the group consisting of hexamethylene diisocyanate, isophorone diisocyanate, trimethyl hexamethylene diisocyanate, and dicyclohexylmethane diisocyanate; and
about 1 to about 5 parts per part polyether polyol of 1,4-butanediol, as a chain extender, andwherein the coating expansion solution comprises at least 50 milligrams of at least one biologically active compound per milliliter of a mixture of ethanol and tetrahydrofuran in ratio of about 2;
1 to about 20;
1 by volume; and
then,(b) drying the thus contacted polymer coating by first subjecting the polymer coating to room temperature and atmospheric pressure, for about 2 minutes to about 15 minutes, and thereafter subjecting the polymer coating to a temperature of about 20°
C. to about 100°
C. at a pressure of about 100 millimeter Hg to about 500 millimeter Hg for about 4 hours to about 16 hours.
-
-
27. A method of making an article for localized delivery of a biologically active compound to a subject, said method comprising:
-
(a) treating a medical-grade, polyurethane polymer coating on a substrate with a coating expansion solution at a temperature, under a pressure and for a time sufficient to cause the biologically active compound to penetrate into the interstices of the polymer coating, said coating having a thickness of at least 20 microns, said coating expansion solution comprising the biologically active compound and an organic solvent system, wherein the organic solvent system comprises at least one solvent for the polymer coating and at least one non-solvent for the polymer coating, wherein the solvent and the non-solvent are present in the organic solvent system at a ratio of solvent to non-solvent in the range of about 1;
1 to about 1;
20 by volume, andwherein the biologically active compound is present in the coating expansion solution in a concentration of at least 0.1 parts per 100 parts of the organic solvent system; and
then(b) drying the thus treated polymer coating to substantially eliminate the organic solvent system.
-
Specification